Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liuhe Animal Pharmaceutical is a leading Chinese manufacturer of veterinary medicines and a core subsidiary of the New Hope Liuhe Group. The company specializes in the research, development, and production of a wide range of animal health products, including chemical drugs, vaccines, and nutritional additives. With multiple GMP-certified production lines, it primarily serves the poultry and swine industries, supporting both its parent company's massive farming operations and external clients. The company is a critical player in the Chinese animal husbandry supply chain, focusing on disease prevention and food safety. Its integration within the New Hope Liuhe ecosystem allows it to leverage extensive resources in agribusiness and biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liu He Animal Pharmaceutical.